ONCY   $1.34  4.69% Market Closed After Close 1.31 -2.24%

Oncolytics Biotech Inc
Last Events:

2023-08-09 Signal in Stochastic changed from bearish to bearish weakening. The stochastic indicator is in the oversold territory and it grows. These factors indicate that perhaps the downside trend is coming to an end. Last signal: main and signal line crossing.

2023-08-09 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-06 Signal in RSI changed from bearish to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-05 Signal in MACD changed from bearish reversal to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and it crossed the zero line from the top. These factors mean that there is probably a falling trend. Last signal: down-crossing the middle level.

2023-08-03 Trend pattern changed from расходящийся клин с наклоном вверх to восходящий клин.

2023-08-03 Signal in EMA50 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-08-02 Signal in RSI changed from bullish recovery to bearish. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-02 Trend Power changed from to medium strength.


Current temperature: 8.54
ST: 6, Cor: -0.00

50-50 Year Forecast
Low with % probability:
Target: 1.15
High with % probability:
Analyst Recommendations:
Number of estimates 4
Target Price Mean 4.830
Mean unverified/preliminary 4.830 / 4.830
Target Price Low / High 4.354 / 4.988
Median / STD DEV 4.988 / 0.44
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy ActivelyBuy ActivelyBuy
rsi Sell ActivelyBuy None
macd None ActivelyBuy None
stoch ActivelyBuy None None
ma20 None ActivelyBuy ActivelyBuy
ma50 ActivelyBuy None None
ma100 ActivelyBuy ActivelyBuy None
Candlestick PatternOct. 8, 2024 Bearish Advance Block Formation - consists of three white bodies with consecutively higher closes in a uptrend. The last two days have long higher shadows. Considered to be a bullish reversal pattern.
ISIN CA6823108759
ceo Dr. Matthew C. Coffey M.B.A., Ph.D.
Website https://www.oncolyticsbiotech.com
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.